C4 Therapeutics, Inc. CCCC
Set alert
3.35 USD -0.02 -0.64%
As of Nov 2, 9:40 AM ET
3.35 Day range 3.41
1.69 52-week range 5.17
- YTD
- +75.32%
- 1 year
- +28.30%
- Open
- 3.36
- Prev close
- 3.37
- Mkt cap
- 412.75M
- Vol
- 57.02K
- Avg vol
- 2.43M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.35
- High
- 3.41
- Forward P/E
- -2.37
- Beta
- 3.06
- Short ratio
- 7.10
- Inst. own
- 91.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 5.06
- 200-d avg
- 5.96
- 1y target
- 15.00
6M chart
Signals (18)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| RSI: Overbought | May 13, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
Ownership
Held by insiders 11.44%
Held by institutions 91.47%
Float held by institutions 103.28%
Institutions 161
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Lynx1 Capital Management Lp | 9.75% | 6,880,527 | 27.93M | Sep 29, 2024 |
| Soleus Capital Management, L.P. | 9.36% | 6,603,996 | 26.81M | Sep 29, 2024 |
| Wasatch Advisors LP | 8.04% | 5,677,368 | 23.05M | Sep 29, 2024 |
| Blackrock Inc. | 6.93% | 4,890,935 | 19.86M | Sep 29, 2024 |
| RA Capital Management, L.P. | 6.91% | 4,878,000 | 19.80M | Sep 29, 2024 |
| Orbimed Advisors LLC. | 6.20% | 4,377,900 | 17.77M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wasatch Ultra Growth Fund | 3.70% | 2,609,942 | 10.60M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 3.03% | 2,135,945 | 8.67M | Sep 29, 2024 |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.34% | 1,653,493 | 6.71M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.17% | 1,534,793 | 6.23M | Oct 30, 2024 |
| Wasatch Microcap Fund | 1.76% | 1,242,144 | 5.04M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.12% | 789,707 | 3.21M | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ADAMS KENDRA | Chief Financial Officer | Conversion of Exercise of derivative security | Nov 6, 2024 | 84,439 |
| ANDERSON KENNETH CARL | Director | Stock Award(Grant) | Sep 30, 2024 | 320,418 |
| BOYLE SCOTT N | Officer | Conversion of Exercise of derivative security | Nov 6, 2024 | 56,567 |
| DUBIN GLENN R. | Director | Stock Award(Grant) | Mar 31, 2024 | 812,682 |
| FISHER STEWART | Officer | Conversion of Exercise of derivative security | Sep 15, 2024 | 130,710 |
| GROGAN DONNA ROY M.D. | Director | Stock Award(Grant) | Sep 30, 2024 | 28,942 |
Held by funds
60 US ETFs and mutual funds hold CCCC · largest positions